brimonidine tartrate has been researched along with Bleeding in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cetinkaya, S; Ucar, F | 2 |
Abraham, E; Arcaroli, J; Kupfner, J; Park, JS; Pitts, TM; Strassheim, D; Yang, KY; Yum, HK | 1 |
3 other study(ies) available for brimonidine tartrate and Bleeding
Article | Year |
---|---|
The Results of Preoperative Topical Brimonidine Usage in Pterygium Surgery.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Conjunctiva; Female; Hemorrhage; Humans; Hyperemia; Male; Middle Aged; Postoperative Complications; Preoperative Care; Pterygium; Retrospective Studies; Scleritis; Vasoconstriction | 2020 |
The Results of Preoperative Use of Topical Brimonidine in Strabismus Surgery.
Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Case-Control Studies; Child; Conjunctival Diseases; Eye Hemorrhage; Female; Hemorrhage; Hemostasis, Surgical; Humans; Hyperemia; Incidence; Intraoperative Complications; Male; Ophthalmic Solutions; Photography; Postoperative Period; Preoperative Care; Retrospective Studies; Strabismus; Young Adult | 2021 |
Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Brimonidine Tartrate; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Endotoxemia; Enzyme Activation; Hemorrhage; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neuroimmunomodulation; Neutrophils; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peroxidase; Phentolamine; Phenylephrine; Phosphorylation; Propranolol; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Quinoxalines; Respiratory Distress Syndrome; Ribosomal Protein S6 Kinases | 2002 |